Pancreatitis
Pancreatitis
Pancreatitis
METHODS OF CONSERVATIVE
TREATMENT OF ACUTE PANCREATITIS.
CONSERVATIVE THERAPY (1)
For acute edematous pancreatitis
1. It is expedient to administer fasting in the first 1–3 days of the disease (to provide physiological
rest of the gland) and intake of alkaline solutions every 2 hours (for example, sodium bicarbonate —
0.5–0.6 mg for a glass of water or mineral water “Borzhomi”).
2. Aspiration of the gastric contents through the probe to prevent ingress of the hydrochloric acid
into the duodenum.
3. Analgesics — to fight with pain syndrome (preferably nonnarcotics, in some cases — tramal,
tramadol, moradol).
5. M-choline blockers (atropin, platiphilin, gastrocepin) — to suppress secretion of the pancreas and
remove spasm of its ducts.
I. In I and II periods (the period of hemodynamic disorders and pancreatogenic shock and the period of polyorganic insufficiency)
Basic therapy should be started immediately after establishment of the diagnosis of “severe pancreatitis” (within 2 hours of
hospitalization):
2. Decompression of the stomach with the probe with periodic aspiration of the gastric contents.
3. Suppression of the external secretory activity of the pancreas for correction of release of the pancreatic enzymes in blood and
adjacent cavities and tissues is one of the main components of intensive treatment of patients with acute disease and damage of this
organ. Suppression of the external secretory activity may be achieved by several ways:
— introduction of antienzymes in blood or locally, first of all antiproteases (contrical, aprotinin, trasilol, gordox, pantripin, 2-
macroglobulin);
— physical methods with application of intragastric or external (mostly zonal) therapeutic hypothermy.
a) somatostatin (sandostatin R (NOVARTIS) 0.1 mg 3 times a day sub- cutaneously for 5–7 days;
Blockers of the pancreas secretion should be administered only in the first 5–7 days of the disease,
and drugs of somastatin — in development of arrosive bleedings and fistula (pancreatic, intestinal).
5. Antioxidants:
— ceruloplasmin 100 mg a day for 5–7 days (as a stimulator of haemo- poiesis may be used in anemia in patients with
purulent-necrotic complica- tions).
6. Analgesics for controling pain syndrome: nonnarcotic (baralgin, keta- nov), narcotic (except morphine, which causes spasm
of the Oddi’s sphinc- ter and may aggravate the patient’s state), peridural anesthesia or other types of blockade with local
anesthetics (paranephral blockade, blockade of the round hepatic ligament, sacrospinal blockade, intracutaneous blockade of
the abdominal plexus by Capisse).
7. Spasmolytics for facilitation of pancreas secretion outflow: myo- tropic (no-spa, papaverin, buscopan, galidor), M-
cholinoblockers (atro- pin, platiphilin, gastroceptin), the latter also reduce secretion of the pan- creatic juice.
8. Stimulators of the intestinal motility — fight with intestinal paresis: ubretid 0.5 mg, repeated introduction not earlier than in
24 hours; benzo- hexamenthonium 2.5% 0.5 ml twice a day; peridural anesthesia.
— carbopenems (tienam 500 mg 3–4 times a day i/v dropwise; meronem 500–1,000 mg i/v dropwise once a day).
— fluochinols (ciprofloxacin 500–750 mg twice a day, ofloxacin (Tariv- id) 400–800 mg twice a day i/v dropwise,
pefloxacin (abactal) 400 mg twice a day i/v dropwise;
All antibiotics (except carbopenems) should be combined with antianaer- obic drugs that are introduced parenterally
(metragil, trichopol).
The course of antibioticotherapy of not less than 14 days is always complemented by antimycotic therapy (ketoconasol
(nisoral) 200 mg per day, fluconasol (diflucan) 50–400 mg per day.
14. Prevention of translocation of the intestinal microflora (i. e. barrier dysfunction of the intestinal wall):
— correction of metabolic disorders and restoration of the barrier func- tion of the intestine (glutamin, arginin, antioxidants);
— enteral feeding as early as possible (insertion of the probe in the initial section of the small intestine intraoperatively (when the
patient has been operated on) or endoscopically;
16. Hepatoprotectors: essentiale, carsil, legalon (the former is not ad- ministered in cholestasis, the latter two ones — in chronic
active hepatitis). In presence of affection of target-organs (respiratory-distress syndrome,
Basic therapy:
levamisol);
THANK YOU